These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 978138)
1. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. Shiku H; Takahashi T; Oettgen HF J Exp Med; 1976 Oct; 144(4):873-81. PubMed ID: 978138 [TBL] [Abstract][Full Text] [Related]
2. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476 [TBL] [Abstract][Full Text] [Related]
3. Serological analysis of cell surface antigens of malignant human brain tumors. Pfreundschuh M; Shiku H; Takahashi T; Ueda R; Ransohoff J; Oettgen HF; Old LJ Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5122-6. PubMed ID: 283420 [TBL] [Abstract][Full Text] [Related]
4. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens. Albino AP; Lloyd KO; Houghton AN; Oettgen HF; Old LJ J Exp Med; 1981 Dec; 154(6):1764-78. PubMed ID: 6976407 [TBL] [Abstract][Full Text] [Related]
6. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines]. Watanabe T Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976 [TBL] [Abstract][Full Text] [Related]
7. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Carey TE; Takahashi T; Resnick LA; Oettgen HF; Old LJ Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3278-82. PubMed ID: 1067619 [TBL] [Abstract][Full Text] [Related]
8. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. Shiku H; Takahashi T; Resnick LA; Oettgen HF; Old LJ J Exp Med; 1977 Mar; 145(3):784-9. PubMed ID: 233917 [TBL] [Abstract][Full Text] [Related]
9. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine]. Takeyama H; Watanabe T; Livingston PO Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307 [TBL] [Abstract][Full Text] [Related]
10. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients. Saxton RE; Irie RF; Ferrone S; Pellegrino MA; Morton DL Int J Cancer; 1978 Mar; 21(3):299-306. PubMed ID: 204583 [TBL] [Abstract][Full Text] [Related]
12. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines. Livingston PO; Kaelin K; Pinsky CM; Oettgen HF; Old LJ Cancer; 1985 Nov; 56(9):2194-200. PubMed ID: 4052966 [TBL] [Abstract][Full Text] [Related]
13. Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells. Livingston PO; Takeyama H; Pollack MS; Houghton AN; Albino A; Pinsky CM; Oettgen HF; Old LJ Int J Cancer; 1983 May; 31(5):567-75. PubMed ID: 6852975 [TBL] [Abstract][Full Text] [Related]
14. Cell surface antigens of human renal cancer defined by autologous typing. Ueda R; Shiku H; Pfreundschuh M; Takahashi T; Li LT; Whitmore WF; Oettgen HF; Old LJ J Exp Med; 1979 Sep; 150(3):564-79. PubMed ID: 479762 [TBL] [Abstract][Full Text] [Related]
15. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. Darrow TL; Slingluff CL; Seigler HF J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141 [TBL] [Abstract][Full Text] [Related]
16. Antibodies and antigen expression in human melanoma detected by the immune adherence test. Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492 [TBL] [Abstract][Full Text] [Related]
17. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Dippold WG; Lloyd KO; Li LT; Ikeda H; Oettgen HF; Old LJ Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6114-8. PubMed ID: 6934537 [TBL] [Abstract][Full Text] [Related]
18. Tumor-specific antigens. Pfreundschuh M; Shiku H; Takahashi T; Ueda R; Ransohoff J; Oettgen HF; Old LJ Recent Results Cancer Res; 1980; 75():1-9. PubMed ID: 7232821 [TBL] [Abstract][Full Text] [Related]
19. Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines. The TH; Huiges HA; Schraffordt Koops H; Lamberts HB; Nieweg HO Ann N Y Acad Sci; 1975 Jun; 254():528-40. PubMed ID: 1101782 [TBL] [Abstract][Full Text] [Related]
20. Serological detection of common human melanoma membrane antigens by microcomplement fixation and immunofluorescence. Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Fried RM; Krementz ET Oncology; 1983; 40(2):95-101. PubMed ID: 6338430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]